Analyst Price Target is $242.40
▲ +10.00% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for STERIS in the last 3 months. The average price target is $242.40, with a high forecast of $255.00 and a low forecast of $233.00. The average price target represents a 10.00% upside from the last price of $220.36.
Current Consensus is
The current consensus among 6 investment analysts is to buy stock in STERIS. This Buy consensus rating has held steady for over two years.
STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers portfolio of infection prevention, procedural, and gastrointestinal solutions. The Healthcare Specialty Services segment delivers solutions and managed services including hospital sterilization services and instrument, and scope repairs to acute care hospitals and other healthcare settings. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capitalequipment. The Applied Sterilization Technologies segment involves in contract sterilization and testing services for medical device and pharmaceutical manufacturer. The company was founded in 1985 and is headquartered in Dublin, Ireland.